S1 Episode 3: How Can ctDNA Testing Improve Bladder Cancer Care? cover art

S1 Episode 3: How Can ctDNA Testing Improve Bladder Cancer Care?

S1 Episode 3: How Can ctDNA Testing Improve Bladder Cancer Care?

Listen for free

View show details

About this listen

Drs Cheryl Lee and Peter Black share exciting new ways to use liquid biopsy ctDNA testing for bladder cancer diagnostics and patient monitoring.

Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/970413). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Adjuvant Atezolizumab Versus Observation in Muscle-Invasive Urothelial Carcinoma (Imvigor010): A Multicentre, Open-Label, Randomised, Phase 3 Trial https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495594/

ctDNA Guiding Adjuvant Immunotherapy in Urothelial Carcinoma https://www.nature.com/articles/s41586-021-03642-9

ClinicalTrials.gov: Treatment of Metastatic Bladder Cancer at the Time of Biochemical reLApse Following Radical Cystectomy (TOMBOLA) https://clinicaltrials.gov/ct2/show/NCT04138628
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.